Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.24 | 6e-12 |
mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-10 |
mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-09 |
mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.25 | 6e-09 |
mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-07 |
mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.3 | 2e-05 |
mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.29 | 4e-05 |
mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.2 | 8e-05 |
mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |